Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial
Authors
Keywords
-
Journal
Lancet Diabetes & Endocrinology
Volume 9, Issue 9, Pages 595-605
Publisher
Elsevier BV
Online
2021-08-04
DOI
10.1016/s2213-8587(21)00179-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
- (2021) Tiffany M. Powell-Wiley et al. CIRCULATION
- Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
- (2020) John B. Buse et al. DIABETES CARE
- Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions
- (2020) Aliza Hussain et al. Current Atherosclerosis Reports
- Reproducibility and repeatability of MRI‐based body composition analysis
- (2020) Magnus Borga et al. MAGNETIC RESONANCE IN MEDICINE
- Colchicine in Patients with Chronic Coronary Disease
- (2020) Stefan M. Nidorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Exercise and Pharmacological Interventions on Visceral Adiposity: A Systematic Review and Meta-analysis of Long-term Randomized Controlled Trials
- (2019) Shreya Rao et al. MAYO CLINIC PROCEEDINGS
- Novel genetic locus of visceral fat and systemic inflammation
- (2019) Jean Shin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A double-blind, placebo-controlled, randomised trial to assess the effect of liraglutide on ectopic fat accumulation in South Asian type 2 diabetes patients
- (2019) Huub J. van Eyk et al. Cardiovascular Diabetology
- Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial
- (2019) Christian Anholm et al. ATHEROSCLEROSIS
- Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation
- (2019) Maurice B. Bizino et al. DIABETOLOGIA
- Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016
- (2018) Craig M. Hales et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Precision of MRI-based body composition measurements of postmenopausal women
- (2018) Janne West et al. PLoS One
- Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study
- (2018) Niina Matikainen et al. DIABETES OBESITY & METABOLISM
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fifty Years of Behavioral/Lifestyle Interventions for Overweight and Obesity: Where Have We Been and Where Are We Going?
- (2017) Donald A. Williamson Obesity
- Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events
- (2016) Rohan Khera et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Feasibility of MR-Based Body Composition Analysis in Large Scale Population Studies
- (2016) Janne West et al. PLoS One
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- (2015) Caroline M. Apovian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Body Fat Distribution and Incident Cardiovascular Disease in Obese Adults
- (2015) Ian J. Neeland et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Validation of a fast method for quantification of intra-abdominal and subcutaneous adipose tissue for large-scale human studies
- (2015) Magnus Borga et al. NMR IN BIOMEDICINE
- Automatic and quantitative assessment of regional muscle volume by multi-atlas segmentation using whole-body water-fat MRI
- (2015) Anette Karlsson et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
- (2013) T A Wadden et al. INTERNATIONAL JOURNAL OF OBESITY
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults
- (2013) Ian J. Neeland et al. Obesity
- Body Fat Distribution and Risk of Cardiovascular Disease
- (2012) Jean-Pierre Després CIRCULATION
- Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults
- (2012) Ian J. Neeland et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
- (2011) A Astrup et al. INTERNATIONAL JOURNAL OF OBESITY
- Impact of Abdominal Visceral and Subcutaneous Adipose Tissue on Cardiometabolic Risk Factors: The Jackson Heart Study
- (2010) Jiankang Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue
- (2009) J. Jendle et al. DIABETES OBESITY & METABOLISM
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now